Olaparib in People With Malignant Mesothelioma

NCT03531840 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

NIH

Sponsor class

Conditions

Mesothelioma

Interventions

DRUG: Olaparib
DEVICE: ClinOmics

Sponsor

National Cancer Institute (NCI)